Genetic Aspects of Primary Headache

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Molecular and Cellular Neuroscience".

Deadline for manuscript submissions: closed (25 April 2021) | Viewed by 5040

Special Issue Editors


E-Mail Website
Guest Editor
Department of Neuroscience, Karolinska Institutet, Biomedicum D7, Stockholm, Sweden
Interests: genetics; headache; neuroscience; pain; circadian rhythm; neurology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Neuroscience, Karolinska Institutet, Biomedicum D7, Stockholm, Sweden
Interests: genetics; migraine; cluster headache; gene expression; pharmacogenetics; neuroscience
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Primary headache disorders are one of the leading causes of disability worldwide, with a global prevalence among adults of around 50%. These disorders are characterized by recurrent headaches, and associated with personal and societal burdens of pain, disability, damaged quality of life, and financial cost. Nevertheless, headache disorders have been underestimated, under-recognized, and under-treated throughout the world. The primary headaches include four main groups: migraine, tension-type headache, trigeminal autonomic cephalalgias (TACs), and other primary headache disorders. Migraine is the most common primary headache disorder, affecting one in seven people, and has been reported to have a strong genetic component. Rare monogenic subtypes of migraine have been identified, where mutations are found in ion channels, while genetic studies in the common forms of migraine had more limited success until 2010, when the first genome-wide association study (GWAS) was reported for migraine by et al. (Nature Genetics). Since then, more than 40 susceptibility loci that affect risk for migraine have been identified including evidence for involvement of both neuronal and vascular mechanisms. Tension-type headache has so far been reported to be caused by a combination of genetic and environmental factors when frequent, while primarily caused by environmental factors when infrequent. A genetic component has been suggested for the most common form of TACs (cluster headache) involving key regulators of circadian rhythm and the neuropeptide calcitonin gene-related peptide (CGRP), however demonstrated associations presently lack replicability. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare type of TAC. The occurrence of SUNCT has been described, which raises the possibility that SUNCT and possibly other TACs will eventually all be considered to be of genetic predisposition.

This Special Issue of Brain Sciences will focus on the progress that has been made towards understanding the disease mechanisms behind primary headache disorders, with a focus on genetics.

Dr. Andrea Carmine Belin

Dr. Caroline Ran
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Migraine
  • Cluster headache
  • GWAS
  • Pain
  • Treatment
  • CGRP
  • Biomarker

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 269 KiB  
Article
PER Gene Family Polymorphisms in Relation to Cluster Headache and Circadian Rhythm in Sweden
by Felicia Jennysdotter Olofsgård, Caroline Ran, Carmen Fourier, Catalina Wirth, Christina Sjöstrand, Elisabet Waldenlind, Anna Steinberg and Andrea Carmine Belin
Brain Sci. 2021, 11(8), 1108; https://doi.org/10.3390/brainsci11081108 - 23 Aug 2021
Cited by 1 | Viewed by 2236
Abstract
The trigeminal autonomic cephalalgia, cluster headache (CH), is one of the most painful disorders known to man. One of the disorder’s most striking features is the reported diurnal rhythmicity of the attacks. For a majority of patients, the headache attacks occur at approximately [...] Read more.
The trigeminal autonomic cephalalgia, cluster headache (CH), is one of the most painful disorders known to man. One of the disorder’s most striking features is the reported diurnal rhythmicity of the attacks. For a majority of patients, the headache attacks occur at approximately the same time every day. Genetic variants of genes involved in the circadian rhythm such as Period Circadian Regulator 1, 2, and 3 (PER1, 2 and 3) are hypothesized to have an effect on the rhythmicity of the attacks. Six PER1, 2 and 3 genetic markers; the indel rs57875989 and five single nucleotide polymorphisms (SNPs), rs2735611, rs2304672, rs934945, rs10462020, and rs228697, were genotyped, using TaqMan® or regular polymerase chain reaction (PCR), in a Swedish CH case control material. Logistic regression showed no association between CH and any of the six genetic variants; rs57875989, p = 0.523; rs2735611, p = 0.416; rs2304672, p = 0.732; rs934945, p = 0.907; rs10462020, p = 0.726; and rs228697, p = 0.717. Furthermore, no difference in allele frequency was found for patients reporting diurnal rhythmicity of attacks, nor were any of the variants linked to diurnal preference. The results of this study indicate no involvement of these PER genetic variants in CH or diurnal phenotype in Sweden. Full article
(This article belongs to the Special Issue Genetic Aspects of Primary Headache)
8 pages, 417 KiB  
Article
Analysis of NOS Gene Polymorphisms in Relation to Cluster Headache and Predisposing Factors in Sweden
by Caroline Ran, Julia M. Michalska, Carmen Fourier, Christina Sjöstrand, Elisabet Waldenlind, Anna Steinberg and Andrea C. Belin
Brain Sci. 2021, 11(1), 34; https://doi.org/10.3390/brainsci11010034 - 31 Dec 2020
Cited by 5 | Viewed by 2260
Abstract
Cluster headache is characterized by activation of the autonomic-trigeminal reflex. Nitric oxide can trigger headaches in patients, and nitric oxide signaling is known to be affected in cluster headache. Based on the hypothesis of nitric oxide being involved in cluster headache pathophysiology we [...] Read more.
Cluster headache is characterized by activation of the autonomic-trigeminal reflex. Nitric oxide can trigger headaches in patients, and nitric oxide signaling is known to be affected in cluster headache. Based on the hypothesis of nitric oxide being involved in cluster headache pathophysiology we investigated nitric oxide synthases as potential candidate genes for cluster headache. We analyzed eight variants in the three forms of nitric oxide synthase (NOS) genes, inducible NOS (iNOS), endothelial NOS (eNOS) and neuronal NOS (nNOS), and tested for association with cluster headache. Swedish cluster headache patients (n = 542) and controls (n = 581) were genotyped using TaqMan® assays on an Applied Biosystems 7500 qPCR cycler. This is the largest performed genetic study on NOS involvement in cluster headache so far. We found an association between cluster headache and one iNOS haplotype consisting of the minor alleles of rs2297518 and rs2779249 (p = 0.022). In addition, one of the analyzed nNOS variants, rs2682826, was associated with reported triptan use (p = 0.039). Our data suggest that genetic variants in NOS genes do not have a strong influence on cluster headache pathophysiology, but that certain combinations of genetic variants in NOS genes may influence the risk of developing the disorder or triptan use. Full article
(This article belongs to the Special Issue Genetic Aspects of Primary Headache)
Show Figures

Figure 1

Back to TopTop